NOD1 and obesity disorder: For example, certain types of LPS and NOD1 ligands can promote insulin resistance and are shown to be augmented in circulation following high‐fat feeding or during obesity (Cani et al., 2007; Chan et al., 2017; Schertzer et al., 2011).